Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.

Ahnström J, Andersson HM, Hockey V, Meng Y, McKinnon TA, Hamuro T, Crawley JT, Lane DA.

Blood. 2012 Dec 13;120(25):5059-62. doi: 10.1182/blood-2012-05-432005. Epub 2012 Oct 16.

2.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Reglińska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JT, Lane DA, Ahnström J.

Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.

3.

The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Ndonwi M, Tuley EA, Broze GJ Jr.

Blood. 2010 Aug 26;116(8):1344-51. doi: 10.1182/blood-2009-10-246686. Epub 2010 May 17.

4.

Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

Somajo S, Ahnström J, Fernandez-Recio J, Gierula M, Villoutreix BO, Dahlbäck B.

Thromb Haemost. 2015 May;113(5):976-87. doi: 10.1160/TH14-09-0803. Epub 2015 Feb 26.

PMID:
25716664
5.

Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.

Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M.

J Thromb Haemost. 2014 Nov;12(11):1826-37. doi: 10.1111/jth.12713. Epub 2014 Oct 12.

6.

The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.

Burgering MJ, Orbons LP, van der Doelen A, Mulders J, Theunissen HJ, Grootenhuis PD, Bode W, Huber R, Stubbs MT.

J Mol Biol. 1997 Jun 13;269(3):395-407.

PMID:
9199408
7.

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.

Santamaria S, Reglińska-Matveyev N, Gierula M, Camire RM, Crawley JTB, Lane DA, Ahnström J.

J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

8.

Protein S is a cofactor for tissue factor pathway inhibitor.

Rosing J, Maurissen LF, Tchaikovski SN, Tans G, Hackeng TM.

Thromb Res. 2008;122 Suppl 1:S60-3. doi: 10.1016/S0049-3848(08)70021-5. Review.

PMID:
18691502
9.

The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.

Peraramelli S, Suylen DP, Rosing J, Hackeng TM.

Thromb Haemost. 2012 Aug;108(2):266-76. doi: 10.1160/TH11-12-0902. Epub 2012 May 25.

PMID:
22627666
10.

Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.

Wood JP, Ellery PE, Maroney SA, Mast AE.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):169-76. doi: 10.1161/ATVBAHA.113.302655. Epub 2013 Nov 14.

11.

Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.

Thomassen MC, Heinzmann AC, Herfs L, Hartmann R, Dockal M, Scheiflinger F, Hackeng TM, Rosing J.

J Thromb Haemost. 2015 Jan;13(1):92-100. doi: 10.1111/jth.12766. Epub 2014 Nov 29.

12.
13.
14.

Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.

Johnson K, Zaror I, Bauer D, Choi Y, Creasey A, Innis M.

Thromb Haemost. 1998 Oct;80(4):585-7.

PMID:
9798974
15.

Role of exosite binding modulators in the inhibition of Fxa by TFPI.

Peraramelli S, Thomassen S, Heinzmann A, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M, Rosing J.

Thromb Haemost. 2016 Mar;115(3):580-90. doi: 10.1160/TH15-04-0354. Epub 2015 Nov 26.

PMID:
26607136
16.

Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes.

Willems GM, Janssen MP, Salemink I, Wun TC, Lindhout T.

Biochemistry. 1998 Mar 10;37(10):3321-8.

PMID:
9521652
17.

Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Dockal M, Hartmann R, Fries M, Thomassen MC, Heinzmann A, Ehrlich H, Rosing J, Osterkamp F, Polakowski T, Reineke U, Griessner A, Brandstetter H, Scheiflinger F.

J Biol Chem. 2014 Jan 17;289(3):1732-41. doi: 10.1074/jbc.M113.533836. Epub 2013 Nov 25.

18.

Tissue factor pathway inhibitor binds to platelet thrombospondin-1.

Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ, Hasty KA, Hall CL.

J Biol Chem. 2000 Oct 13;275(41):31715-21.

19.

Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.

Riesbeck K, Dorling A, Kemball-Cook G, McVey JH, Jones M, Tuddenham EG, Lechler RI.

Thromb Haemost. 1997 Dec;78(6):1488-94.

PMID:
9423800
20.

Supplemental Content

Support Center